Europe Ocular Drug Delivery Market Trends and Analysis by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Europe Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

  • Report Code : TIPRE00025762
  • Category : Life Sciences
  • No. of Pages : 152
Buy Now

The ocular drug delivery market in Europe is expected to grow to US$ 7,921.15 million by 2028 from US$ 4,967.64 million in 2021. The market is estimated to grow at a CAGR of 6.9% from 2021 to 2028.


The incidence of eye diseases has increased significantly. In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, facilitating patients access to suitable medications and treatments for such conditions. Sightsavers—an international non-governmental organization—works in developing countries to treat and prevent eye diseases. A large population of India resides in rural areas, which has limited or no awareness about eye ailments. With its Rural Eye Health Programme, Sightsavers aims to create awareness, provide high-quality eye health services, and eradicate avoidable blindness in the rural population. Thus, the growing eye health awareness programs are likely to create growth opportunities for the market.

The European region has been massively hit by the COVID-19 spread, with most countries being in lockdown. Routine healthcare services were cancelled, and patients were recommended to avoid hospital visits to minimize the risk of COVID-19 transmission, leading to significant disruption to the provision of healthcare service and patient care. Ophthalmology represents one of the busiest and heavily outpatient-oriented specialties, with around 7.5 million outpatient appointments and over 500,000 surgical procedures being conducted every year in the United Kingdom. The lockdown has resulted in the cancellation of thousands of ophthalmic visits and surgeries; this has potentially led to permanent and significant harm to patient’s vision. Additionally, as per the recent survey – ‘Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK’ which was conducted among the public with eye diseases, highlighted a significant negative psychosocial impact of lockdown on patients with visual impairment, with approximately 50% of the patients express fear of sight loss due to delayed review or treatment.

With the new features and technologies, companies can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ocular drug delivery market. The Europe ocular drug delivery market is expected to grow at a good CAGR during the forecast period.
Europe ocular drug delivery market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Ocular Drug Delivery Market Segmentation

 

Europe Ocular Drug Delivery Market – By Technology

  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
  • Others

Europe Ocular Drug Delivery Market – By Formulation Type

  • Solution
  • Ointment
  • Suspension
  • Emulsion
  • Liposomes and Nanoparticles

Europe Ocular Drug Delivery Market – By Disease type

  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Others

Europe Ocular Drug Delivery Market – By End User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Europe Ocular Drug Delivery Market – By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe

Europe Ocular Drug Delivery Market – Companies Mentioned

  • AbbVie Inc.                                              
  • Bausch Health Companies Inc.            
  • Novartis AG                                            
  • Clearside Biomedical, Inc                       
  • Alimera Sciences, Inc.                           
  • GRAYBUG VISION, INC

Europe Ocular Drug Delivery Report Scope

Report Attribute Details
Market size in 2021 US$ 4,967.64 Million
Market Size by 2028 US$ 7,921.15 Million
Global CAGR (2021 - 2028) 6.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
By Formulation Type
  • Liposomes and Nanoparticles
  • Solution
  • Emulsion
  • Suspension
  • Ointment
By Disease Type
  • Glaucoma
  • Diabetic Retinopathy
  • Dry Eye Syndrome
  • Macular Degeneration
  • Cataract
  • Diabetic Macular Edema
By End User
  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Clearside Biomedical, Inc
  • Alimera Sciences, Inc.
  • GRAYBUG VISION, INC
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    europe-ocular-drug-delivery-market-report-deliverables-img1
    europe-ocular-drug-delivery-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Europe Ocular Drug Delivery Market
    Connect With Expert
    1. AbbVie Inc.                                              
    2. Bausch Health Companies Inc.            
    3. Novartis AG                                            
    4. Clearside Biomedical, Inc                      
    5. Alimera Sciences, Inc.                           
    6. GRAYBUG VISION, INC                      
    europe-ocular-drug-delivery-market-cagr